» Articles » PMID: 25612104

Epigenetic and Genetic Alterations Affect the WWOX Gene in Head and Neck Squamous Cell Carcinoma

Overview
Journal PLoS One
Date 2015 Jan 23
PMID 25612104
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Different types of genetic and epigenetic changes are associated with HNSCC. The molecular mechanisms of HNSCC carcinogenesis are still undergoing intensive investigation. WWOX gene expression is altered in many cancers and in a recent work reduced WWOX expression has been associated with miR-134 expression in HNSCC. In this study we investigated the WWOX messenger RNA expression levels in association with the promoter methylation of the WWOX gene and miR-134 expression levels in 80 HNSCC tumor and non-cancerous tissue samples. Our results show that WWOX expression is down-regulated especially in advanced-stage tumor samples or in tumors with SCC. This down-regulation was associated with methylation of the WWOX promoter region but not with miR-134 expression. There was an inverse correlation between the expression level and promoter methylation. We also analyzed whole exons and exon/intron boundries of the WWOX gene by direct sequencing. In our study group we observed 10 different alterations in the coding sequences and 18 different alterations in the non-coding sequences of the WWOX gene in HNSCC tumor samples. These results indicate that the WWOX gene can be functionally inactivated by promoter methylation, epigenetically or by mutations affecting the sequences coding for the enzymatic domain of the gene, functionally. We conclude that inactivation of WWOX gene contributes to the progression of HNSCC.

Citing Articles

Loss of WWOX contributes to cisplatin resistance in triple-negative breast cancer cells by modulating miR-182 and miR-214.

Batar B, Serdal E, Erdal B, Ogul H Turk J Med Sci. 2024; 54(5):1127-1134.

PMID: 39473747 PMC: 11518363. DOI: 10.55730/1300-0144.5891.


Dual Regulation Mechanism of Obesity: DNA Methylation and Intestinal Flora.

Ren Y, Huang P, Zhang L, Tang Y, Luo S, She Z Biomedicines. 2024; 12(8).

PMID: 39200098 PMC: 11351752. DOI: 10.3390/biomedicines12081633.


WWOX and metabolic regulation in normal and pathological conditions.

Baryla I, Kosla K, Bednarek A J Mol Med (Berl). 2022; 100(12):1691-1702.

PMID: 36271927 PMC: 9691486. DOI: 10.1007/s00109-022-02265-5.


Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors.

Patra S, Elahi N, Armorer A, Arunachalam S, Omala J, Hamid I Front Oncol. 2021; 11:700629.

PMID: 34631530 PMC: 8495201. DOI: 10.3389/fonc.2021.700629.


How DNA methylation affects the Warburg effect.

Zhu X, Xuan Z, Chen J, Li Z, Zheng S, Song P Int J Biol Sci. 2020; 16(12):2029-2041.

PMID: 32549751 PMC: 7294934. DOI: 10.7150/ijbs.45420.


References
1.
Iliopoulos D, Fabbri M, Druck T, Qin H, Han S, Huebner K . Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expression. Clin Cancer Res. 2007; 13(1):268-74. DOI: 10.1158/1078-0432.CCR-06-2038. View

2.
Paige A, Taylor K, Taylor C, Hillier S, Farrington S, Scott D . WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A. 2001; 98(20):11417-22. PMC: 58744. DOI: 10.1073/pnas.191175898. View

3.
Bednarek A, Laflin K, Daniel R, Liao Q, Hawkins K, Aldaz C . WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 2000; 60(8):2140-5. View

4.
Haddad R, Shin D . Recent advances in head and neck cancer. N Engl J Med. 2008; 359(11):1143-54. DOI: 10.1056/NEJMra0707975. View

5.
Kuroki T, Yendamuri S, Trapasso F, Matsuyama A, Aqeilan R, Alder H . The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res. 2004; 10(7):2459-65. DOI: 10.1158/1078-0432.ccr-03-0096. View